2025, Australian Register update for tirzepatide: Mounjaro (tirzepatide) received ARTG listing for weight management in addition to its earlier type 2 diabetes listing, expanding the prescribing population
The article gives rough timelines by route: provincial health insurance coverage for diabetes at two to eight weeks after approval, private insurance at one to three weeks post-approval, and out-of-pocket branded purchase at one to two weeks after the prescription is written
Available in flexible 3, 6, and 12-month plans, ColonBroom GLP-1 Booster offers a sustainable approach to weight management and metabolic health for those seeking natural alternatives in 2025
If the needles scare you, then oral semaglutide can be a great option, but it may give you a slower effect than injectable semaglutide
Both formulations come from licensed 503A compounding pharmacies nationwide, require no insurance, and are HSA/FSA eligible